• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

持续性非卧床腹膜透析伴腹膜炎患者腹腔负荷剂量后血清万古霉素浓度的预测

Prediction of serum vancomycin concentrations following intraperitoneal loading doses in continuous ambulatory peritoneal dialysis patients with peritonitis.

作者信息

Bailie G R, Eisele G, Venezia R A, Yocum D, Hollister A

机构信息

Department of Pharmacy Practice, Albany College of Pharmacy, New York.

出版信息

Clin Pharmacokinet. 1992 Apr;22(4):298-307. doi: 10.2165/00003088-199222040-00005.

DOI:10.2165/00003088-199222040-00005
PMID:1606789
Abstract

The pharmacokinetics of vancomycin were studied in continuous ambulatory peritoneal dialysis patients with peritonitis. Six patients received an intraperitoneal loading dose of 15 mg/kg and 4 received an intraperitoneal dose of 25 mg/L. The ability of 2 methods to predict serum concentrations during the loading dose exchange was determined. The mean serum concentration after the exchange was 17.8 +/- 2.2 mg/L in patients receiving the loading dose. The mean dialysis clearance in all patients was 0.94 +/- 0.34 L/h. 66.6 +/- 13.4% of a dose was absorbed into the circulation in 4 h. The volume of distribution was 0.61 +/- 0.46 L/kg, and the half-life for equilibration of vancomycin into the circulation from dialysate was 2.76 +/- 0.94 h. Two methods of predicting serum vancomycin concentrations were tested, with 1 method predicting values significantly different from measured concentrations while the other did not. Serum vancomycin concentrations can be accurately predicted during a loading dose exchange.

摘要

对患有腹膜炎的持续性非卧床腹膜透析患者的万古霉素药代动力学进行了研究。6名患者接受了15mg/kg的腹腔负荷剂量,4名患者接受了25mg/L的腹腔剂量。确定了两种方法预测负荷剂量交换期间血清浓度的能力。接受负荷剂量的患者交换后的平均血清浓度为17.8±2.2mg/L。所有患者的平均透析清除率为0.94±0.34L/h。4小时内66.6±13.4%的剂量被吸收进入循环。分布容积为0.61±0.46L/kg,万古霉素从透析液进入循环的平衡半衰期为2.76±0.94小时。测试了两种预测血清万古霉素浓度的方法,一种方法预测的值与测量浓度有显著差异,而另一种方法则没有。在负荷剂量交换期间可以准确预测血清万古霉素浓度。

相似文献

1
Prediction of serum vancomycin concentrations following intraperitoneal loading doses in continuous ambulatory peritoneal dialysis patients with peritonitis.持续性非卧床腹膜透析伴腹膜炎患者腹腔负荷剂量后血清万古霉素浓度的预测
Clin Pharmacokinet. 1992 Apr;22(4):298-307. doi: 10.2165/00003088-199222040-00005.
2
Clearance from dialysate and equilibration of intraperitoneal vancomycin in continuous ambulatory peritoneal dialysis.持续非卧床腹膜透析中腹透液中万古霉素的清除及腹腔内万古霉素的平衡
Clin Pharmacokinet. 1990 Jun;18(6):485-90. doi: 10.2165/00003088-199018060-00005.
3
Pharmacokinetics of once daily intra-peritoneal aztreonam and vancomycin in the treatment of CAPD peritonitis.
J Antimicrob Chemother. 1990 Jan;25(1):141-7. doi: 10.1093/jac/25.1.141.
4
Vancomycin pharmacokinetics during continuous ambulatory peritoneal dialysis in patients with peritonitis.万古霉素在腹膜炎患者持续性不卧床腹膜透析中的药代动力学。
Eur J Pharm Sci. 2011 Jul 17;43(4):212-6. doi: 10.1016/j.ejps.2011.04.006. Epub 2011 Apr 20.
5
Treatment of gram-positive peritonitis with two intraperitoneal doses of vancomycin in continuous ambulatory peritoneal dialysis patients.持续性非卧床腹膜透析患者腹腔内注射两剂万古霉素治疗革兰氏阳性腹膜炎
Nephron. 1987;45(4):283-5. doi: 10.1159/000184164.
6
Pharmacokinetics of single dose intravenous vancomycin in CAPD peritonitis.持续性非卧床腹膜透析相关性腹膜炎患者单次静脉注射万古霉素的药代动力学
J Antimicrob Chemother. 1987 Mar;19(3):351-7. doi: 10.1093/jac/19.3.351.
7
Once weekly intraperitoneal therapy for gram-positive peritonitis.革兰氏阳性菌腹膜炎的每周一次腹腔内治疗。
Am J Kidney Dis. 1987 Oct;10(4):300-5. doi: 10.1016/s0272-6386(87)80026-4.
8
Intravenous or intraperitoneal vancomycin for the treatment of continuous ambulatory peritoneal dialysis associated gram-positive peritonitis?静脉注射或腹腔内注射万古霉素用于治疗持续性非卧床腹膜透析相关革兰氏阳性菌腹膜炎?
Nephron. 1987;46(3):316-8. doi: 10.1159/000184374.
9
Vancomycin kinetics during continuous ambulatory peritoneal dialysis.持续非卧床腹膜透析期间的万古霉素动力学
Clin Pharmacol Ther. 1983 Nov;34(5):631-7. doi: 10.1038/clpt.1983.225.
10
Disposition of ceftazidime after intraperitoneal administration in adolescent patients receiving continuous cycling peritoneal dialysis.接受持续循环腹膜透析的青少年患者腹腔内给予头孢他啶后的处置情况。
Am J Kidney Dis. 2006 Mar;47(3):503-8. doi: 10.1053/j.ajkd.2005.11.010.

引用本文的文献

1
Pharmacokinetics of Intraperitoneal Vancomycin and Amikacin in Automated Peritoneal Dialysis Patients With Peritonitis.腹膜炎自动腹膜透析患者腹腔内注射万古霉素和阿米卡星的药代动力学
Front Pharmacol. 2021 May 28;12:658014. doi: 10.3389/fphar.2021.658014. eCollection 2021.
2
Vancomycin in peritoneal dialysis: Clinical pharmacology considerations in therapy.万古霉素在腹膜透析中的应用:治疗中的临床药理学考虑。
Perit Dial Int. 2020 Jul;40(4):384-393. doi: 10.1177/0896860819889774. Epub 2020 Feb 17.
3
Vancomycin: the tale of the vanquisher and the pyrrhic victory.

本文引用的文献

1
Pharmacokinetics of vancomycin: observations in 28 patients and dosage recommendations.万古霉素的药代动力学:28例患者的观察结果及剂量建议
Antimicrob Agents Chemother. 1982 Sep;22(3):391-4. doi: 10.1128/AAC.22.3.391.
2
Pharmacokinetics of vancomycin in patients undergoing continuous ambulatory peritoneal dialysis.持续非卧床腹膜透析患者中万古霉素的药代动力学
Antimicrob Agents Chemother. 1984 May;25(5):603-6. doi: 10.1128/AAC.25.5.603.
3
Vancomycin kinetics during continuous ambulatory peritoneal dialysis.持续非卧床腹膜透析期间的万古霉素动力学
万古霉素:征服者的故事与惨胜
Perit Dial Int. 2014 Mar-Apr;34(2):154-61. doi: 10.3747/pdi.2014.00001.
4
Clinical pharmacokinetics during continuous ambulatory peritoneal dialysis.持续性非卧床腹膜透析期间的临床药代动力学
Clin Pharmacokinet. 1996 Oct;31(4):293-308. doi: 10.2165/00003088-199631040-00005.
Clin Pharmacol Ther. 1983 Nov;34(5):631-7. doi: 10.1038/clpt.1983.225.
4
Vancomycin disposition during continuous ambulatory peritoneal dialysis: a pharmacokinetic analysis of peritoneal drug transport.持续性非卧床腹膜透析期间万古霉素的处置:腹膜药物转运的药代动力学分析
Antimicrob Agents Chemother. 1985 Apr;27(4):578-82. doi: 10.1128/AAC.27.4.578.
5
Intravenous or intraperitoneal vancomycin for the treatment of continuous ambulatory peritoneal dialysis associated gram-positive peritonitis?静脉注射或腹腔内注射万古霉素用于治疗持续性非卧床腹膜透析相关革兰氏阳性菌腹膜炎?
Nephron. 1987;46(3):316-8. doi: 10.1159/000184374.
6
Comparative study of intraperitoneal and intravenous vancomycin pharmacokinetics during continuous ambulatory peritoneal dialysis.持续非卧床腹膜透析期间腹腔内和静脉注射万古霉素药代动力学的比较研究
Antimicrob Agents Chemother. 1987 Feb;31(2):173-7. doi: 10.1128/AAC.31.2.173.
7
Clinical pharmacokinetics of vancomycin.万古霉素的临床药代动力学
Clin Pharmacokinet. 1986 Jul-Aug;11(4):257-82. doi: 10.2165/00003088-198611040-00001.
8
The 1987 USA National CAPD Registry report.1987年美国持续性非卧床腹膜透析登记报告。
ASAIO Trans. 1988 Apr-Jun;34(2):150-6. doi: 10.1097/00002480-198804000-00013.
9
The epidemiology of peritonitis caused by coagulase-negative staphylococci in continuous ambulatory peritoneal dialysis.持续性非卧床腹膜透析中凝固酶阴性葡萄球菌所致腹膜炎的流行病学
J Med Microbiol. 1989 Nov;30(3):167-74. doi: 10.1099/00222615-30-3-167.
10
Clearance from dialysate and equilibration of intraperitoneal vancomycin in continuous ambulatory peritoneal dialysis.持续非卧床腹膜透析中腹透液中万古霉素的清除及腹腔内万古霉素的平衡
Clin Pharmacokinet. 1990 Jun;18(6):485-90. doi: 10.2165/00003088-199018060-00005.